Biotech, Health Services, and Medical Devices Drive August 2025 Healthcare Transactions

In August, healthcare transactions surpassed $32B in disclosed value, led by platform-scale acquisitions and high-growth investments across biotech, health services, and medical devices.

Key Insights:

Strategic Mega-Merger: Mallinckrodt’s $6.7B merger with Endo Pharmaceuticals anchored biotech deal flow.
Home Health Leadership: UnitedHealth’s $3.3B acquisition of Amedisys expanded its continuum of care.
Dermatology Specialty Exit: EQT’s $2.6B secondary sale of Galderma reflected strong demand in skin health.
Innovative Devices: HistoSonics’ $2.3B buyout and Terumo’s $1.5B OrganOx acquisition showcased momentum in non-invasive and transplant-enabling technologies.
Provider Platforms: Cardinal Health’s $1.9B Solaris Health acquisition underscored consolidation in specialty care delivery.

Download the August 2025 Healthcare Transactions Report!

Written By: Dakota Research

Related Content

Betting, Analytics, and Institutional Capital Headline the November Edition of Dakota Sports Investing
November 06, 2025

Aerospace, Logistics, and Automation Drive September 2025 Industrial Transactions
October 21, 2025

Real Assets, Private Credit, and AI Rebound Lead Q3 2025 Institutional Allocations
October 16, 2025

October 14, 2025 Investor News: Illinois Firefighters Accelerates Alts Buildout, and more...
October 14, 2025

Biotech, Value-Based Care, and Digital Health Drive September 2025 Healthcare Transactions
October 14, 2025

The Database For Cold Outreach to Reach Institutional and RIA Investors

Book A Demo

Biotech, Health Services, and Medical Devices Drive August 2025 Healthcare Transactions

Subscribe

Related Content

The Database For Cold Outreach to Reach Institutional and RIA Investors

Address

Products & Services

Resources

Podcasts

Events

Company